KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $12.3 billion.

  • Gilead Sciences' Total Current Liabilities rose 488.7% to $12.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 billion, marking a year-over-year increase of 488.7%. This contributed to the annual value of $12.0 billion for FY2024, which is 641.84% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Total Current Liabilities is $12.3 billion, which was up 488.7% from $11.2 billion recorded in Q2 2025.
  • Gilead Sciences' 5-year Total Current Liabilities high stood at $14.0 billion for Q2 2023, and its period low was $8.6 billion during Q1 2022.
  • In the last 5 years, Gilead Sciences' Total Current Liabilities had a median value of $11.2 billion in 2022 and averaged $11.2 billion.
  • As far as peak fluctuations go, Gilead Sciences' Total Current Liabilities surged by 5145.34% in 2023, and later plummeted by 2279.43% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Total Current Liabilities stood at $11.6 billion in 2021, then dropped by 3.21% to $11.2 billion in 2022, then grew by 0.38% to $11.3 billion in 2023, then grew by 6.42% to $12.0 billion in 2024, then grew by 2.45% to $12.3 billion in 2025.
  • Its last three reported values are $12.3 billion in Q3 2025, $11.2 billion for Q2 2025, and $12.3 billion during Q1 2025.